Atlas Trials

Immorna Biotherapeutics, Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Immorna Biotherapeutics, Inc.

RecordFirmDate
One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors (NCT06781125)Immorna Biotherapeutics, Inc.2026-03-18
A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine (NCT06581575)Immorna Biotherapeutics, Inc.2024-10-16
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV (NCT06564194)Immorna Biotherapeutics, Inc.2024-09-25
A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine (NCT05871541)Immorna Biotherapeutics, Inc.2023-05-26
A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine (NCT05743335)Immorna Biotherapeutics, Inc.2023-03-07
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors (NCT05727839)Immorna Biotherapeutics, Inc.2023-02-24
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors (NCT05539157)Immorna Biotherapeutics, Inc.2022-10-18

Track Immorna Biotherapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.